MentionFox
Home › Executive changes › Organogenesis Holdings Inc.
Leadership changes · ORGO · SEC Form 8-K, Item 5.02

Leadership changes at Organogenesis Holdings Inc. (2026)

Before you join, sell to or invest in Organogenesis Holdings Inc.

MentionFox check on Organogenesis Holdings Inc.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/organogenesis-holdings

Check Organogenesis Holdings Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Organogenesis Holdings Inc.?

Who joined and who left Organogenesis Holdings Inc. (ORGO)? 1 appointment reported on 2026-02-23, each cited to the company's own filing.

Patrick McGuire was named Chief Accounting Officer of Organogenesis Holdings Inc. As of November 14, 2026, Organogenesis Holdings Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on February 23, 2026, naming 1 appointment (Form 8-K, February 23, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

First Light Asset Management, LLC also filed stake reports on 12 other companies ↓

Sell to companies like Organogenesis Holdings Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
In (appointed)1
Latest filing2026-02-23

Organogenesis Holdings Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-02-23. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Organogenesis Holdings Inc. files it.

Also on the record for Organogenesis Holdings Inc.

DateRecordFigureOur pageSource
February 17, 2026Stake report, Schedule 13G/A, by Mathew P. Arens3.06% of the class5%+ stakesSource
February 12, 2026Stake report, Schedule 13G/A, by Soleus Capital Master Fund, L.P.7.9% of the class5%+ stakesSource
November 3, 2025Stake report, Schedule 13D/A, by Glenn H. Nussdorf9.7% of the class5%+ stakesSource
August 14, 2025Stake report, Schedule 13G, by Mathew P. Arens6.55% of the class5%+ stakesSource
November 27, 2024Form D, private offering$130M soldForm D pageSource

Selling to them or working with them? See who runs Organogenesis Holdings Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on Organogenesis Holdings Inc. and the records around it.

Organogenesis Holdings Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on Organogenesis Holdings Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Organogenesis Holdings Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Organogenesis Holdings Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    6 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-02-23InChief Accounting Officer8-K, 2026-02-23

Who leads Organogenesis Holdings Inc., as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to Organogenesis Holdings Inc.?

New leaders reset buying decisions — get the Full Report on Organogenesis Holdings Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Organogenesis Holdings Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the Chief Accounting Officer at Organogenesis Holdings Inc., with the record behind each one.

Find candidates like Chief Accounting Officer at Organogenesis Holdings Inc.

Every change, in the filing's words

Filed 2026-02-23 · 8-K

Appointed: Patrick McGuire, Chief Accounting Officer

On February 18, 2026, the board of directors of Organogenesis Holdings Inc. (the "Company") appointed Patrick McGuire, 40, to serve as Chief Accounting Officer and principal accounting officer of the Company, effective immediately.

Also stated in this filing

  • Patrick McGuire previously served as the Company's Vice President, Corporate Controller since September 2023.
  • Prior to joining the Company, Mr. McGuire was the Corporate Controller at Cynosure, LLC from July 2022 to September 2023 and worked at PricewaterhouseCoopers LLP for over thirteen years in various roles, with an emphasis on pharmaceutical, life sciences and medical device organizations, most recently as a Director from July 2019 to July 2022.
  • Mr. McGuire holds a B.A. in Economics and Accounting from the College of the Holy Cross and is a licensed Certified Public Accountant in the state of Massachusetts.
  • In connection with Mr. McGuire's appointment as Chief Accounting Officer and principal accounting officer, his annual base salary was increased to $345,000.
  • No other changes to Mr. McGuire's existing compensation arrangements were made in connection with his appointment.

Tools for this story

Each opens in a new tab, filled in for Organogenesis Holdings Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/organogenesis-holdings
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Who joined Organogenesis Holdings Inc.? (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/organogenesis-holdings